|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/32 | (2006.01) | ||
| G01N 33/574 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1984402 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06841231.1 |
| Date of filing the European patent application | 2006-12-29 | |
| (97) | Date of publication of the European application | 2008-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-08 |
| (46) | Date of publication of the claims translation | 2017-04-10 |
| (86) | Number | PCT/EP2006/012632 |
| Date | 2006-12-29 |
| (87) | Number | WO 2007/077028 |
| Date | 2007-07-12 |
| (30) | Number | Date | Country code |
| 755103 P | 2005-12-30 | US |
| (72) |
ROTHE, Mike, DE
TREDER, Martin, DE
HARTMANN, Susanne, DE
FREEMAN, Dan, US
RADINSKY, Bob, US
BORGES, Eric, AT
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
Daiichi Sankyo Europe GmbH, Zielstattstr. 48, 81379 München, DE |
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Antikūnai, nukreipti į HER-3, ir jų panaudojimai |
| ANTIBODIES DIRECTED TO HER-3 AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-11-21 | 20 | 347.00 EUR |